课题基金 / 基金详情

Improving the Clinical Efficacy and Safety Profile of Repurposed COVID-19 Drugs

Improving the Clinical Efficacy and Safety Profile of Repurposed COVID-19 Drugs
提高重新利用的 COVID-19 药物的临床疗效和安全性
批准号：
458246
负责人：
Nwabufo Chukwunonso K
金额：
$7.65万
依托单位：
University of Toronto
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-11-01 至 2024-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=458246&lang=en
关键词：
Chronic Obstructive Pulmonary Disease Coronavirus Disease 2019 Covid-19-Associated Neurocognitive Dysfunction Disease - Drug Interactions Drug - Drug Interactions Drug Metabolism And Disposition Drug Metabolizing Enzymes Membrane-Associated Drug Tr

项目摘要

项目成果

Nwabufo Chukwunonso K的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The COVID-19 global health crisis has altered the socioeconomic and financial wellbeing of many nations. To rapidly address this problem, scientists began developing vaccines and drugs for the prevention and treatment of the disease. Although vaccines are
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Predicting the Optimal Clinical Dosing Regimen for Promising COVID-19 Drugs
  • 批准号：
    473885
  • 项目类别：
    Miscellaneous Programs
  • 资助金额：
    $0.44万
  • 财政年份：
    2022
  • 负责人：
    Nwabufo Chukwunonso K
  • 依托单位：
    University of Manchester (England)
海外基金